Charles Rhyee
Stock Analyst at TD Cowen
(4.47)
# 1,126
Out of 5,076 analysts
662
Total ratings
55%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Reiterated: Hold | $492 | $653.96 | -24.77% | 16 | Oct 22, 2026 | |
| CVS CVS Health | Reiterated: Buy | $110 | $94.48 | +16.43% | 61 | Oct 9, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $338 | $315.88 | +7.00% | 19 | Sep 30, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $300 → $325 | $339.66 | -4.32% | 25 | Sep 25, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $283 | $322.55 | -12.26% | 22 | Sep 15, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $81 | $60.86 | +33.09% | 12 | Aug 19, 2026 | |
| EVH Evolent Health | Rated: Buy | $5 → $6 | $4.89 | +22.70% | 50 | Aug 17, 2026 | |
| CAH Cardinal Health | Rated: Buy | $275 → $280 | $255.64 | +9.53% | 40 | Aug 13, 2026 | |
| DRIO DarioHealth | Rated: Hold | $11 → $8 | $3.41 | +134.60% | 18 | Aug 12, 2026 | |
| GDRX GoodRx Holdings | Rated: Buy | $4 → $5 | $3.62 | +38.12% | 37 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $45 | $34.88 | +29.01% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $338.48 | +18.18% | 51 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $989 → $1,006 | $1,012.34 | -0.63% | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $14.19 | -15.43% | 21 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $23 | $23.92 | -3.85% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $185.57 | +6.16% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $6.32 | -5.06% | 59 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $28.98 | +44.93% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $31.30 | -26.52% | 7 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $213 → $288 | $278.32 | +3.48% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.90 | +63.27% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.15 | +261.45% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $29.91 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $113.49 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.84 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $226.68 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.000001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $415 | $424.98 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $395 | $445.28 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $33.32 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $80 | $71.24 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $410 → $460 | $420.97 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $216.64 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $29 | $37.09 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $20.40 | n/a | 1 | Feb 25, 2014 |
Medpace Holdings
Oct 22, 2026
Reiterated: Hold
Price Target: $492
Current: $653.96
Upside: -24.77%
CVS Health
Oct 9, 2026
Reiterated: Buy
Price Target: $110
Current: $94.48
Upside: +16.43%
The Cigna Group
Sep 30, 2026
Reiterated: Buy
Price Target: $338
Current: $315.88
Upside: +7.00%
Charles River Laboratories International
Sep 25, 2026
Rated: Buy
Price Target: $300 → $325
Current: $339.66
Upside: -4.32%
Veeva Systems
Sep 15, 2026
Reiterated: Buy
Price Target: $283
Current: $322.55
Upside: -12.26%
BrightSpring Health Services
Aug 19, 2026
Reiterated: Buy
Price Target: $81
Current: $60.86
Upside: +33.09%
Evolent Health
Aug 17, 2026
Rated: Buy
Price Target: $5 → $6
Current: $4.89
Upside: +22.70%
Cardinal Health
Aug 13, 2026
Rated: Buy
Price Target: $275 → $280
Current: $255.64
Upside: +9.53%
DarioHealth
Aug 12, 2026
Rated: Hold
Price Target: $11 → $8
Current: $3.41
Upside: +134.60%
GoodRx Holdings
Aug 11, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.62
Upside: +38.12%
Aug 10, 2026
Rated: Buy
Price Target: $53 → $45
Current: $34.88
Upside: +29.01%
Aug 9, 2026
Reiterated: Buy
Price Target: $400
Current: $338.48
Upside: +18.18%
Aug 6, 2026
Rated: Buy
Price Target: $989 → $1,006
Current: $1,012.34
Upside: -0.63%
Aug 5, 2026
Rated: Hold
Price Target: $8 → $12
Current: $14.19
Upside: -15.43%
Aug 4, 2026
Reiterated: Buy
Price Target: $18 → $23
Current: $23.92
Upside: -3.85%
Aug 3, 2026
Rated: Buy
Price Target: $197
Current: $185.57
Upside: +6.16%
Aug 3, 2026
Reiterated: Hold
Price Target: $6
Current: $6.32
Upside: -5.06%
Aug 3, 2026
Reiterated: Buy
Price Target: $42
Current: $28.98
Upside: +44.93%
Aug 2, 2026
Reiterated: Hold
Price Target: $23
Current: $31.30
Upside: -26.52%
Jul 29, 2026
Rated: Buy
Price Target: $213 → $288
Current: $278.32
Upside: +3.48%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $4.90
Upside: +63.27%
Nov 13, 2025
Reiterated: Buy
Price Target: $15
Current: $4.15
Upside: +261.45%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $29.91
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $113.49
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $25.84
Upside: n/a
Oct 30, 2023
Reiterated: Buy
Price Target: $170
Current: $226.68
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Reiterated: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Reiterated: Buy
Price Target: $370 → $415
Current: $424.98
Upside: n/a
Apr 14, 2021
Reiterated: Buy
Price Target: $360 → $395
Current: $445.28
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $33.32
Upside: n/a
Feb 8, 2021
Reiterated: Buy
Price Target: $74 → $80
Current: $71.24
Upside: n/a
Feb 1, 2021
Reiterated: Hold
Price Target: $410 → $460
Current: $420.97
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $216.64
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: $30 → $29
Current: $37.09
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $20.40
Upside: n/a